JGC
BSX icon

J. Goldman & Co’s Boston Scientific BSX Stock Holding History

J. Goldman & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.67M Buy
+42,500
New +$3.4M 0.08% 274
2015
Q2 		– Sell
-86,900
Closed -$1.54M – 249
2015
Q1 		$1.54M Sell
86,900
-78,600
-47% -$1.24M 0.1% 204
2014
Q4 		$2.19M Buy
+165,500
New +$2.12M 0.26% 113

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

J. Goldman & Co's BSX Position: Q1 2026 in Review

J. Goldman & Co opened a new position in Boston Scientific (BSX) in Q1 2026: 44,485 shares worth $2.79M. The stake represents 0.08% of the portfolio and ranks #269 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in BSX as recently as Q1 2024.

J. Goldman & Co first reported a position in BSX in Q3 2013 and has held it in 12 quarters since. The position peaked at $16.3M in Q1 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • J. Goldman & Co held 44,485 shares of Boston Scientific worth $2.79M as of Q1 2026.
  • Boston Scientific was a new J. Goldman & Co position in Q1 2026.
  • Boston Scientific made up 0.08% of J. Goldman & Co's portfolio in Q1 2026, its #269 holding.
  • J. Goldman & Co first reported a position in Boston Scientific in Q3 2013 and has held it in 12 quarters since.
  • J. Goldman & Co's Boston Scientific position peaked at $16.3M in Q1 2019.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.